These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 29847700)

  • 1. Inflammasomes: a novel therapeutic target in pulmonary hypertension?
    Scott TE; Kemp-Harper BK; Hobbs AJ
    Br J Pharmacol; 2019 Jun; 176(12):1880-1896. PubMed ID: 29847700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes as immune targets in arterial hypertension.
    Wenzel P
    Br J Pharmacol; 2019 Jun; 176(12):1966-1977. PubMed ID: 29885051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019.
    Scott TE; Qin CX; Drummond GR; Hobbs AJ; Kemp-Harper BK
    Hypertension; 2021 Nov; 78(5):1168-1184. PubMed ID: 34565184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction.
    Weiss A; Boehm M; Egemnazarov B; Grimminger F; Savai Pullamsetti S; Kwapiszewska G; Schermuly RT
    Br J Pharmacol; 2021 Jan; 178(1):31-53. PubMed ID: 31709514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?
    Nunes KP; de Oliveira AA; Mowry FE; Biancardi VC
    Br J Pharmacol; 2019 Jun; 176(12):1864-1879. PubMed ID: 29981161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemokines and chemokine receptors in pulmonary arterial hypertension.
    Mamazhakypov A; Viswanathan G; Lawrie A; Schermuly RT; Rajagopal S
    Br J Pharmacol; 2021 Jan; 178(1):72-89. PubMed ID: 31399998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of pulmonary hypertension: Getting to the heart of the problem.
    Dignam JP; Scott TE; Kemp-Harper BK; Hobbs AJ
    Br J Pharmacol; 2022 Mar; 179(5):811-837. PubMed ID: 33724447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice.
    Cero FT; Hillestad V; Sjaastad I; Yndestad A; Aukrust P; Ranheim T; Lunde IG; Olsen MB; Lien E; Zhang L; Haugstad SB; Løberg EM; Christensen G; Larsen KO; Skjønsberg OH
    Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(4):L378-87. PubMed ID: 26071556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.
    Rajagopal K; Bryant AJ; Sahay S; Wareing N; Zhou Y; Pandit LM; Karmouty-Quintana H
    Br J Pharmacol; 2021 Jan; 178(1):172-186. PubMed ID: 32128790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy.
    Chelladurai P; Boucherat O; Stenmark K; Kracht M; Seeger W; Bauer UM; Bonnet S; Pullamsetti SS
    Br J Pharmacol; 2021 Jan; 178(1):54-71. PubMed ID: 31749139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension: a new treatment for an old disease? Targeting the immune system.
    Bomfim GF; Cau SBA; Bruno AS; Fedoce AG; Carneiro FS
    Br J Pharmacol; 2019 Jun; 176(12):2028-2048. PubMed ID: 29969833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future treatments of pulmonary arterial hypertension.
    Sommer N; Ghofrani HA; Pak O; Bonnet S; Provencher S; Sitbon O; Rosenkranz S; Hoeper MM; Kiely DG
    Br J Pharmacol; 2021 Jan; 178(1):6-30. PubMed ID: 32034759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Gredic M; Blanco I; Kovacs G; Helyes Z; Ferdinandy P; Olschewski H; Barberà JA; Weissmann N
    Br J Pharmacol; 2021 Jan; 178(1):132-151. PubMed ID: 31976545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
    Shirasuna K; Karasawa T; Takahashi M
    J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.
    Alexander MR; Norlander AE; Elijovich F; Atreya RV; Gaye A; Gnecco JS; Laffer CL; Galindo CL; Madhur MS
    Br J Pharmacol; 2019 Jun; 176(12):2015-2027. PubMed ID: 29774543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of immune cells in hypertension.
    Caillon A; Paradis P; Schiffrin EL
    Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell trafficking, lymphatics and hypertension.
    Balasubbramanian D; Lopez Gelston CA; Rutkowski JM; Mitchell BM
    Br J Pharmacol; 2019 Jun; 176(12):1978-1988. PubMed ID: 29797446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity and hypertension: New targets to lighten the pressure.
    Vinh A; Drummond GR; Sobey CG
    Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt, inflammation, IL-17 and hypertension.
    Wenzel UO; Bode M; Kurts C; Ehmke H
    Br J Pharmacol; 2019 Jun; 176(12):1853-1863. PubMed ID: 29767465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Rac1 Signaling Downregulates Inflammasome Activation and Attenuates Lung Injury in Neonatal Rats Exposed to Hyperoxia.
    Hummler JK; Dapaah-Siakwan F; Vaidya R; Zambrano R; Luo S; Chen S; Kerr N; de Rivero Vaccari JP; Keane RW; Dietrich WD; Bancalari E; Young KC; Wu S
    Neonatology; 2017; 111(3):280-288. PubMed ID: 28013306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.